Monthly Archives: June 2017

Featured Stories

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Louisiana Whistleblower Lawsuit Revived

Louisiana Whistleblower Lawsuit Revived

A state appeals court in Louisiana has ruled that a former employee of Rapides Parish Coliseum can proceed with a whistleblower lawsuit against the Coliseum Authority.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

FDA Warning Letters for Bodybuilding Products Containing Steroid-Like Substances

On June 20, 2017, the U.S. Food and Drug Administration (FDA) posted warning letters to Flex Fitness/Big Dan’s Fitness, AndroPharm, and Hardcore Formulations for illegally marketing products labeled as containing steroid and steroid-like substances and promoted to increase muscle mass and strength. The products are … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals |

FDA Investigates Hepatitis A Linked to Frozen Tuna

The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), are assisting state and local officials in assessing the risk of hepatitis A virus exposure from contaminated frozen tuna from Sustainable Seafood Company, Vietnam, … Continue reading

Posted in Food Poisoning, Health Concerns |

Another Try for MDL for PPI Lawsuits – Kidney Damage Allegations

Proton pump inhibitors (PPIs) such as Nexium, Prilosec, and Prevacid are drugs used in the treatment of acid reflux or heartburn. Plaintiffs have filed lawsuits alleging that these medications caused kidney injuries and have filed a motion to consolidate 172 … Continue reading

Posted in Health Concerns, Nexium, Pharmaceuticals |

More Than 400 Cases in Viagra-Melanoma Multidistrict Litigation

As of May 15, 2017, 428 men are plaintiffs in a Viagra (sildenafil) multidistrict product liability litigation in U.S. District Court for the Northern District of California. The suit alleges that the “little blue pill,” manufactured by Pfizer, is connected … Continue reading

Posted in Health Concerns, Pharmaceuticals, Viagra |

Johnson & Johnson Loses Fourth Transvaginal Mesh Trial

On May 26, 2017, health care giant Johnson & Johnson lost its fourth surgical mesh lawsuit when a Philadelphia jury returned a verdict of $2.16 million against Johnson & Johnson and its Ethicon Women’s Health and Urology division. Observers see … Continue reading

Posted in Defective Medical Devices, Transvaginal mesh |

MusclMasster Recalls Al-ER-G Capsules due to Ephedra

MusclMasster, LLC, is recalling all bottles of Al-Er-G Capsules due to the presence of Ephedra Herb, an ingredient that has been banned by the U.S. Food and Drug Administration (FDA). Dietary supplements that contain ephedrine alkaloids pose a risk of … Continue reading

Posted in Health Concerns, Product Recalls, Recalled Food Products |

Multicounty Litigation Created for Stryker LFIT V40 Hip Lawsuits

Stryker LFIT V40 Hip Implant Lawsuits Consolidated into Multicounty Litigation The New Jersey Supreme Court has decided to consolidate state lawsuits over the Stryker LFIT V40 hip implants into a multicounty litigation. Plaintiffs allege injuries from the LFIT Anatomic Cobalt … Continue reading

Posted in Legal News |

“Superbug” Bacteria Live in One-Quarter of Nursing Home Residents

Antibiotic-Resistant Bacteria Affects 1 in 4 Nursing Home Residents New findings suggest that one in four nursing home residents has antibiotic-resistant bacteria, or “superbugs”. Researchers reviewed findings from eight previous studies and found that the rate of multidrug-resistant bacteria ranged … Continue reading

Posted in Legal News |

Products Africana Receives FDA Warning Letter for Violations

FDA Letter Says Products are “Adulterated” Due to Manufacturing Violations New Jersey-based Products Africana has received a warning letter from the U.S. Food and Drug Administration (FDA) stating that the company has violated Current Good Manufacturing (CGMP) Regulations in Manufacturing, … Continue reading

Posted in Legal News |

FDA Cites Sweet Springs Valley Water Co. for E. Coli Contamination

Sweet Springs Valley Water Co. Receives FDA Warning Letter The U.S. Food and Drug Administration (FDA) has cited Sweet Springs Valley Water Co. for violating federal regulations regarding its bottled water products. The agency sent a warning letter stating that … Continue reading

Posted in Legal News |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.